Welcome to Chinese Journal of Clinical Pharmacology and Therapeutics,Today is Chinese

Chinese Journal of Clinical Pharmacology and Therapeutics ›› 1996, Vol. 1 ›› Issue (2): 109-111.

Previous Articles     Next Articles

Effect of Lacidipine for Patents with Essential Hypertension and its Effect on Plasma Endothelin and Angiotensin Ⅱ Level

Shi Xiangyun, Zhu Zhiming, Tian Huisheng, Cao Yuean, Zang Guiming, Zhao Yuetao, Xue Fanhua, Nie Zhijun   

  1. Navy General Hospital, Beijing 100037
  • Received:1996-07-02 Revised:1996-08-23 Published:2020-12-03

Abstract: Aim The effect of lacidipine for patients with essential hypertension and its effect on plasma endothelin and angiotensin Ⅱ level were observed. Methods Forty patients with essential hyper-tension were treated with lacidipine 4-8 mg 1/d,for 4 weeks. Ambulatory blood pressure monitor-ing(ABPM) was carried out in 20 patients. Result The responsive rate was 67.5%,the total ef-fective rate was 92. 5%. SBP,DBP and MAP were decreased 28. 40,19.7 and 22. 7 mmHg,re-spectively. The total effective rate in patients with essential hypertension in stage I, Ⅱ was higher than that in patients in stage Ⅲ. We also found the plasma endothelin and angiotensin I level were decreased after lacidipine treatment. Conclusion The results suggest that lacidipine is a drug of stabilization, persistance, low dose (1/d) and good toleration for the treatment of essential hypertension.

Key words: Lacidipine, Hypertension, Endothelin, Angiotensin Ⅱ

CLC Number: